FDA Staff Scientists Disagree with Advisory Panel on Compounded Peptides

FDA staff scientists are in opposition to an advisory panel's recommendation to ease access to compounded peptides, creating uncertainty about the agency's future actions.

2 Aug, 12:49 — 2 Aug, 12:49

Post Share

Sources

Showing 1 of 1 sources

forbes5h ago

On Peptides, FDA Staff Scientists At Odds With Advisory Panel

Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, because FDA staff are opposed to easing access.

By Joshua P. Cohen, Senior Contributor

Read full article →

PERSPECTA

PERSPECTA

FDA Staff Scientists Disagree with Advisory Panel on Compounded Peptides

Sources

On Peptides, FDA Staff Scientists At Odds With Advisory Panel

Related Stories

MTN Ghana to Use Ghana Card for MoMo Loan Defaulter Detection

Decline of Convertibles and Sunroofs in Automotive Market

New Grocery Stores Promise Cheaper Prices in New York City

Micron Technology Stock Plummets Amid Analyst Caution

PERSPECTA